Myasthenia Gravis after Hepatitis B Vaccine [2];Myasthénie Après Vaccination Anti-Hépatite B

Therapie

Volumn 58, Issue 4, 2003, Pages 378-379

  Louzir, Bassem ^a   Othmani, Salah ^a   Battikh, Riadh ^a   Abdelhafidh, Nédia Ben ^a   Bahri, Mer ^a   Taalouche, Leïla ^a   Bahri, Mohamed ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

Hepatitis B vaccine; Myasthenia gravis

Indexed keywords

CHOLINESTERASE INHIBITOR; CYCLOSPORIN; H B VAX II; HEPATITIS B VACCINE; PREDNISOLONE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ALLERGY; ANAMNESIS; ASTHMA; CASE REPORT; CLINICAL FEATURE; HEPATITIS B; HUMAN; LETTER; MYASTHENIA GRAVIS; POLLEN ALLERGY; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

EID: 0345304891     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2003059     Document Type: Letter

References (7)

1. Massani V, Maison P, Descendos JC, et al. Six years of sentinel surveillance of hepatitis B in general practice in France. Eur J Epidemiol 1998; 14: 765-7
2. Iniguez C, Mauri JA, Larrode I, et al. Acute transverse myelitis secondary to hepatitis B vaccination. Rev Neurol 2000 Sep 1-15; 31 (5): 430-2
3. Carmeli Y, De-Medina T. Serious hepatitis B vaccine adverse reactions: are they immune-mediated? Vaccine 1993; 11: 1358-9
4. Soubeyrand B, Boisnard F, Bruel M, et al. Pathologies démyélinisantes du système nerveux central rapportées après vaccination hépatite B par GenHevac B®. Presse Med 2000; 29: 775-80
5. Biron P, Montpetit P, Infante-Rivard CL, et al. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med 1988; 148: 2685
6. Domigo V, Authier FJ, Bachoud-Levi AC, et al. Should hepatitis B vaccine be contra-indicated in myasthenia gravis? Autoimmunity 1999; 29: 139-40
7. Bégaud B, Evreux JC, Jouglard J, et al. Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France. Thérapie 1985; 40: 111-8